Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgan E Grams

Showing results (191-200 of 420) with videos related to

Pageof 42
Sort By:
Nature Genetics|May 2, 2022
Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studiesJingning Zhang, Diptavo Dutta, Anna Köttgen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 26, 2020
Association Between Midlife Obesity and Kidney Function Trajectories: The Atherosclerosis Risk in Communities (ARIC) StudyZhi Yu, Morgan E Grams, Chiadi E Ndumele, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 3, 2021
Biomarkers of Immune Activation and Incident Kidney Failure With Replacement Therapy: Findings From the African American Study of Kidney Disease and HypertensionTeresa K Chen, Michelle M Estrella, Lawrence J Appel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 10, 2018
Prevalence of Opioid, Gabapentinoid, and NSAID Use in Patients with CKDTessa K Novick, Aditya Surapaneni, Jung-Im Shin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 5, 2019
Associations of Opioid Prescriptions with Death and Hospitalization across the Spectrum of Estimated GFRTessa K Novick, Aditya Surapaneni, Jung-Im Shin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 15, 2022
Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A Scientific Workshop Cosponsored by the National Kidney Foundation and the US Food and Drug AdministrationLesley A Inker, Morgan E Grams, Hrefna Guðmundsdóttir, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 3, 2017
<i>APOL1</i> Risk Variants and Cardiovascular Disease: Results From the AASK (African American Study of Kidney Disease and Hypertension)Teresa K Chen, Lawrence J Appel, Morgan E Grams, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2021
Mortality and Access to Kidney Transplantation in Patients with Sickle Cell Disease-Associated Kidney FailureSunjae Bae, Morgan Johnson, Allan B Massie, et al.
Kidney International|September 4, 2017
Plasma galectin-3 levels are associated with the risk of incident chronic kidney diseaseCasey M Rebholz, Elizabeth Selvin, Menglu Liang, et al.
Journal of the American Heart Association|April 6, 2019
Albuminuria as a Predictor of Cardiovascular Outcomes in Patients With Acute Myocardial InfarctionYejin Mok, Shoshana H Ballew, Yingying Sang, et al.
Pageof 42

Showing results (191-200 of 420) with videos related to

Sort By:
Pageof 42
Nature Genetics|May 2, 2022
Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studiesJingning Zhang, Diptavo Dutta, Anna Köttgen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 26, 2020
Association Between Midlife Obesity and Kidney Function Trajectories: The Atherosclerosis Risk in Communities (ARIC) StudyZhi Yu, Morgan E Grams, Chiadi E Ndumele, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 3, 2021
Biomarkers of Immune Activation and Incident Kidney Failure With Replacement Therapy: Findings From the African American Study of Kidney Disease and HypertensionTeresa K Chen, Michelle M Estrella, Lawrence J Appel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 10, 2018
Prevalence of Opioid, Gabapentinoid, and NSAID Use in Patients with CKDTessa K Novick, Aditya Surapaneni, Jung-Im Shin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 5, 2019
Associations of Opioid Prescriptions with Death and Hospitalization across the Spectrum of Estimated GFRTessa K Novick, Aditya Surapaneni, Jung-Im Shin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 15, 2022
Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A Scientific Workshop Cosponsored by the National Kidney Foundation and the US Food and Drug AdministrationLesley A Inker, Morgan E Grams, Hrefna Guðmundsdóttir, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 3, 2017
<i>APOL1</i> Risk Variants and Cardiovascular Disease: Results From the AASK (African American Study of Kidney Disease and Hypertension)Teresa K Chen, Lawrence J Appel, Morgan E Grams, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2021
Mortality and Access to Kidney Transplantation in Patients with Sickle Cell Disease-Associated Kidney FailureSunjae Bae, Morgan Johnson, Allan B Massie, et al.
Kidney International|September 4, 2017
Plasma galectin-3 levels are associated with the risk of incident chronic kidney diseaseCasey M Rebholz, Elizabeth Selvin, Menglu Liang, et al.
Journal of the American Heart Association|April 6, 2019
Albuminuria as a Predictor of Cardiovascular Outcomes in Patients With Acute Myocardial InfarctionYejin Mok, Shoshana H Ballew, Yingying Sang, et al.
Pageof 42